1) ACTOS
盐酸匹格列酮
2) ACTOS
匹格列酮盐酸盐
3) pioglitazone
匹格列酮
1.
Effect of pioglitazone on the proliferation and differentiation of orbit preadipocytes in healthy adults and patients with thyroid-associated ophthalmopathy;
匹格列酮对正常人和甲状腺相关眼病患者眼眶前脂肪细胞增殖和分化的影响
2.
Effects of Pioglitazone on the expression of tumor necrosis factor-α(TNF-α)in the renal of diabetic rats;
匹格列酮对糖尿病大鼠TNF-α表达的影响
3.
Effect of Pioglitazone on Inflammatory Markers in Type 2 Diabetes Mellitus;
匹格列酮对2型糖尿病炎症标志物的影响研究
4) Pioglitazone Hydrochloride
盐酸吡格列酮
1.
Research to manufacture the Pioglitazone Hydrochloride orally disintegrating tablets;
盐酸吡格列酮口腔崩解片的研制
2.
Determination of Pioglitazone Hydrochloride Tablets by HPLC;
盐酸吡格列酮片的HPLC含量测定方法
5) pioglitazone hydrochloride tablets
盐酸吡格列酮片
1.
Dissolution comparison of pioglitazone hydrochloride tablets from different producers by process analysis;
过程分析比较不同厂家盐酸吡格列酮片的溶出度
2.
Pharmacokinetics of pioglitazone hydrochloride tablets in healthy human subjects after a single dose administration;
单剂口服盐酸吡格列酮片在健康人体的药代动力学
3.
Studies on the dissoulution rate of pioglitazone hydrochloride tablets;
盐酸吡格列酮片的溶出度研究
6) Pioglitazone
盐酸吡格列酮
1.
Effects of pioglitazone on the insulin resistance in the muscle tissue;
盐酸吡格列酮对肌肉组织胰岛素抵抗发生的影响
2.
Study on the prevention of insulin resistance of pioglitazone in the rats induced by high-fat diet;
盐酸吡格列酮对高脂诱导大鼠胰岛素抵抗的干预作用
3.
The clinical research of Pioglitazone treating typeⅡdiabeties;
盐酸吡格列酮治疗2型糖尿病临床研究
补充资料：盐酸匹格列酮
分子式：C19H20N2O3S·HCl
分子量：392.90
CAS号：112529-15-4
性质：外观 白色晶体粉末熔程 193-194℃
制备方法：暂无
用途：新一代二型糖尿病治疗药，副作用小。
分子量：392.90
CAS号：112529-15-4
性质：外观 白色晶体粉末熔程 193-194℃
制备方法：暂无
用途：新一代二型糖尿病治疗药，副作用小。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条